Health Care/Hospital
REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools
BELTSVILLE, Md., Jan. 29, 2026 /PRNewswire/ -- REPROCELL today announced the commercial launch ofStemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveragingOpenCRISPR-1™, an AI-designed genome editing system licensed from Profluent (Emeryville, CA, USA). StemEd...
2026-01-28 22:00
4735
NYSE Content Advisory: Pre-Market Update + First Lady Melania Trump to Ring NYSE Bell for Doc 'Melania'
NEW YORK, Jan. 28, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + First Lady Melania Tr...
2026-01-28 21:55
7123
Sciwind Biosciences Published T2DM Phase III EECOH-1 Trial Results of Ecnoglutide in Nature Communications
HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Recently, the results of the pivotal Phase III clinical trial (EECOH-1) of ecnoglutide injection, developed by Sciwind Biosciences Co., Ltd. ("Sciwind"), for the monotherapy of type 2 diabetes (T2DM), have been published in Nature Communications. Con...
2026-01-28 19:39
4498
CHCC 2026 Opens Registration, Offering a One-Stop Platform for Hospital Construction Solutions and Real-World Applications
TIANJIN, China, Jan. 28, 2026 /PRNewswire/ -- The 27th China Hospital Construction Conference & International Hospital Build and Infrastructure Exposition (CHCC 2026), a globally recognized hospital construction event, will be held from May 23 to 25, 2026, at the National Convention and Exhibitio...
2026-01-28 15:01
4550
US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy
The US Food and Drug Administration (FDA) has approved Novo Nordisk's new once-daily pill for weight management, designed to help people reduce excess body weight and maintain weight reduction over the long term. In clinical trials, patients achieved an average weight reduction of 16.6% from base...
2026-01-28 10:45
5889
Organizations Without AI Security Policies Are Already Behind, Warns Armor
Armor releases AI governance framework to address critical policy gap as
enterprise AI adoption accelerates
DALLAS, Jan. 28, 2026 /PRNewswire/ -- Armor, a leading provider of
cloud-nativemanaged detection and response (MDR)
2026-01-28 02:21
4028
Home Control Signs Memorandum of Understanding with NTU Singapore to Explore AIoT Home Healthcare Ecosystem
HONG KONG, Jan. 27, 2026 /PRNewswire/ -- Home Control International Limited (" Home Control" or the "Company", together with its subsidiaries, the "Group"; Stock Code: 1747.HK) is pleased to announce that it has entered into a Strategic Memorandum of Understanding (MoU) with Nanyang Technological ...
2026-01-27 21:25
6535
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural history expected worsening of cUHDRS in symptomatic patients of -0.73 points over nine months, based on propensity score weighting. Skyhawk also ann...
2026-01-27 21:00
5363
Libevitug Approved in China as First-in-Class Hepatitis D Treatment
BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis. Libevitug is a hum...
2026-01-27 16:15
5070
Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030
* Servier reported Group revenues of €6.9 billion for 2024/25, up 16.2% from 2023/24. * Growth over the financial year was driven by increased sales in oncology, particularly in the United States. * Several partnership agreements in oncology and neurology strengthen the Group's R&D portfoli...
2026-01-27 16:00
4373
3Shape appoints Rasmus Hannemann as Senior Vice President, Portfolio & Product Strategy
COPENHAGEN, Denmark, Jan. 27, 2026 /PRNewswire/ -- 3Shape today announced the appointment of Rasmus Hannemann as Senior Vice President, Portfolio & Product Strategy, effective 9 March. Rasmus will step into the Senior Leadership Team and will report directly to CEO Jacob Paulsen. Rasmus joins 3S...
2026-01-27 15:45
4376
Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year
GOTHENBURG, Sweden, Jan. 27, 2026 /PRNewswire/ -- "We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year," says Mattias Perjos, President & CEO at Getinge. Higher demand for consumables for ECL...
2026-01-27 15:23
3498
Davos Spotlight | EVYD, Ministry of Health Brunei Darussalam and Novartis Foundation Launch National AI-Powered Cardiovascular Disease Prevention Initiative
DAVOS, Switzerland, Jan. 27, 2026 /PRNewswire/ -- At the 2026 World Economic Forum Annual Meeting in Davos, Dr. Giovanni Caforio, Chairman of the Board of Directors of Novartis, announced a major new partnership: the Novartis Foundation, the Ministry of Health of Brunei Darussalam, and EVYD Techn...
2026-01-27 14:37
6939
Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary disease
SHANGHAI, Jan. 27, 2026 /PRNewswire/ -- Nuance Pharma ("Nuance") today announced that the National Medical Products Administration (NMPA) of China has officially accepted for review the New Drug Application (NDA) for Ohtuvayre® (ensifentrine) for the maintenance treatment of chronic obstructive p...
2026-01-27 10:13
4032
Unlock the Future of Health and Food Innovation: Hi & Fi Asia-China 2026 Pre-Registration Now Open
SHANGHAI, Jan. 27, 2026 /PRNewswire/ -- Leveraging the solid foundation laid by its highly renowned 2025 edition, Hi & Fi Asia-China, Asia's premier platform for health ingredients and food innovation, is delighted to announce the official launch of pre-registration for its 2026 edition. Schedule...
2026-01-27 10:00
4318
Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology
SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of HER2-positive gastric or gastroesophageal junction cancer (GC/GEJ) of anbenitamab injection (KN026), independently developed by the ...
2026-01-27 09:58
4912
ICP DAS-BMP at WHX Dubai 2026 Spotlights Low-Migration and Low-Friction TPU
HSINCHU, Jan. 27, 2026 /PRNewswire/ -- ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation inWHX Dubai 2026 (formerly Arab Health), taking place from 9 to 12 February at the Dubai ...
2026-01-27 09:17
4928
New "MedTech Advance" Sourcing Directory Launches to Streamline Global Medical Device Manufacturing
Comprehensive e-book accelerates product development by connecting R&D and procurement teams with global suppliers. TAICHUNG, Jan. 27, 2026 /PRNewswire/ -- Today marks the official release of MedTech Advance, a comprehensive digital buyer's directory engineered to accelerate the sourcing process...
2026-01-27 09:00
3108
Heartbeats Shareholder Mr Lu Min Yong Honoured as "Global Chinese Role Model" at the 2026 Spring Festival Gala Evening
SYDNEY and BEIJING, Jan. 27, 2026 /PRNewswire/ -- Heartbeats proudly congratulates its shareholder,Lu Min Yong, on being awarded the title of "全球华人楷模" (Global Chinese Role Model) at theGlobal Chinese Spring Festival Gala Evening held as part of the 2026 Chinese New Year celebrations in Beijing, ...
2026-01-27 08:08
4358
Functional Medicine Malaysia: Emagene Life Academy Officially Launches with Successful "Good Gut Gathering" Workshop
KUALA LUMPUR, Malaysia, Jan. 26, 2026 /PRNewswire/ -- Emagene Life <>, a leading functional medicine and longevity practice in Malaysia, has officially launched the Emagene Life Academy, marking a major milestone in the advancement of functional medicine education in the region. The Academy's lau...
2026-01-27 00:37
5288
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 326 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 301 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09
Most Read
/C O R R E C T I O N -- Republic Power Group Limited (NASDAQ: RPGL)/
2026-02-20 06:36
8004